(2R,6S)-2-methyl-4-(8-methylquinoxalin-5-yl)-6-[[4-(2-piperazin-1-ylpyrimidin-4-yl)piperazin-1-yl]methyl]morpholine

C27H37N9O — CID 156702760

IUPAC(2R,6S)-2-methyl-4-(8-methylquinoxalin-5-yl)-6-[[4-(2-piperazin-1-ylpyrimidin-4-yl)piperazin-1-yl]methyl]morpholine
SMILESCc1ccc(N2C[C@H](CN3CCN(c4ccnc(N5CCNCC5)n4)CC3)O[C@H](C)C2)c2nccnc12
InChIInChI=1S/C27H37N9O/c1-20-3-4-23(26-25(20)29-7-8-30-26)36-17-21(2)37-22(19-36)18-33-13-15-34(16-14-33)24-5-6-31-27(32-24)35-11-9-28-10-12-35/h3-8,21-22,28H,9-19H2,1-2H3/t21-,22+/m1/s1
InChIKeyWAWQFECSMXIEMK-YADHBBJMSA-N
MW503.66 g/mol
LogP1.55
Rot. Bonds5

About (2R,6S)-2-methyl-4-(8-methylquinoxalin-5-yl)-6-[[4-(2-piperazin-1-ylpyrimidin-4-yl)piperazin-1-yl]methyl]morpholine

(2R,6S)-2-methyl-4-(8-methylquinoxalin-5-yl)-6-[[4-(2-piperazin-1-ylpyrimidin-4-yl)piperazin-1-yl]methyl]morpholine (PubChem CID 156702760) has the molecular formula C27H37N9O and a molecular weight of 503.66 g/mol. Its IUPAC name is (2R,6S)-2-methyl-4-(8-methylquinoxalin-5-yl)-6-[[4-(2-piperazin-1-ylpyrimidin-4-yl)piperazin-1-yl]methyl]morpholine.

Molecular Properties

Compound Name(2R,6S)-2-methyl-4-(8-methylquinoxalin-5-yl)-6-[[4-(2-piperazin-1-ylpyrimidin-4-yl)piperazin-1-yl]methyl]morpholine
PubChem CID156702760
Molecular FormulaC27H37N9O
Molecular Weight503.66 g/mol
Exact Mass503.31
IUPAC Name(2R,6S)-2-methyl-4-(8-methylquinoxalin-5-yl)-6-[[4-(2-piperazin-1-ylpyrimidin-4-yl)piperazin-1-yl]methyl]morpholine
SMILESCc1ccc(N2C[C@H](CN3CCN(c4ccnc(N5CCNCC5)n4)CC3)O[C@H](C)C2)c2nccnc12
InChIInChI=1S/C27H37N9O/c1-20-3-4-23(26-25(20)29-7-8-30-26)36-17-21(2)37-22(19-36)18-33-13-15-34(16-14-33)24-5-6-31-27(32-24)35-11-9-28-10-12-35/h3-8,21-22,28H,9-19H2,1-2H3/t21-,22+/m1/s1
InChIKeyWAWQFECSMXIEMK-YADHBBJMSA-N
XLogP1.55
TPSA85.78 Ų
H-Bond Donors1
H-Bond Acceptors10
Rotatable Bonds5
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500503.66
LogP ≤ 51.55
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1010

Analyze (2R,6S)-2-methyl-4-(8-methylquinoxalin-5-yl)-6-[[4-(2-piperazin-1-ylpyrimidin-4-yl)piperazin-1-yl]methyl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R,6S)-2-methyl-4-(8-methylquinoxalin-5-yl)-6-[[4-(2-piperazin-1-ylpyrimidin-4-yl)piperazin-1-yl]methyl]morpholine?
The IUPAC name of (2R,6S)-2-methyl-4-(8-methylquinoxalin-5-yl)-6-[[4-(2-piperazin-1-ylpyrimidin-4-yl)piperazin-1-yl]methyl]morpholine (CID 156702760) is (2R,6S)-2-methyl-4-(8-methylquinoxalin-5-yl)-6-[[4-(2-piperazin-1-ylpyrimidin-4-yl)piperazin-1-yl]methyl]morpholine.
What is the SMILES notation for (2R,6S)-2-methyl-4-(8-methylquinoxalin-5-yl)-6-[[4-(2-piperazin-1-ylpyrimidin-4-yl)piperazin-1-yl]methyl]morpholine?
The canonical SMILES for (2R,6S)-2-methyl-4-(8-methylquinoxalin-5-yl)-6-[[4-(2-piperazin-1-ylpyrimidin-4-yl)piperazin-1-yl]methyl]morpholine is Cc1ccc(N2C[C@H](CN3CCN(c4ccnc(N5CCNCC5)n4)CC3)O[C@H](C)C2)c2nccnc12.
What is the InChIKey of (2R,6S)-2-methyl-4-(8-methylquinoxalin-5-yl)-6-[[4-(2-piperazin-1-ylpyrimidin-4-yl)piperazin-1-yl]methyl]morpholine?
The InChIKey is WAWQFECSMXIEMK-YADHBBJMSA-N. The full InChI is InChI=1S/C27H37N9O/c1-20-3-4-23(26-25(20)29-7-8-30-26)36-17-21(2)37-22(19-36)18-33-13-15-34(16-14-33)24-5-6-31-27(32-24)35-11-9-28-10-12-35/h3-8,21-22,28H,9-19H2,1-2H3/t21-,22+/m1/s1.
What are the key properties of (2R,6S)-2-methyl-4-(8-methylquinoxalin-5-yl)-6-[[4-(2-piperazin-1-ylpyrimidin-4-yl)piperazin-1-yl]methyl]morpholine?
(2R,6S)-2-methyl-4-(8-methylquinoxalin-5-yl)-6-[[4-(2-piperazin-1-ylpyrimidin-4-yl)piperazin-1-yl]methyl]morpholine has a molecular weight of 503.66 g/mol, XLogP of 1.55, 5 rotatable bonds, 1 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,6S)-2-methyl-4-(8-methylquinoxalin-5-yl)-6-[[4-(2-piperazin-1-ylpyrimidin-4-yl)piperazin-1-yl]methyl]morpholine is sourced from PubChem (CID 156702760), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).